Saxon Interests’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
1,217
+334
+38% +$341K 0.4% 57
2026
Q1
$812K Sell
883
-261
-23% -$265K 0.28% 90
2025
Q4
$1.23M Sell
1,144
-12
-1% -$11.5K 0.43% 59
2025
Q3
$847K Buy
1,156
+631
+120% +$470K 0.33% 71
2025
Q2
$434K Hold
525
0.2% 112
2025
Q1
$434K Buy
525
+161
+44% +$134K 0.2% 112
2024
Q4
$281K Sell
364
-80
-18% -$66.2K 0.12% 146
2024
Q3
$393K Buy
444
+105
+31% +$94.4K 0.18% 118
2024
Q2
$307K Buy
339
+4
+1% +$3.2K 0.15% 134
2024
Q1
$261K Buy
+335
New +$238K 0.12% 150

Other funds holding LLY

Saxon Interests's LLY Position: Q2 2026 in Review

Saxon Interests increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $341K and bringing the position to 1,217 shares worth $1.46M. The position accounts for 0.4% of the portfolio, ranked #57.

Saxon Interests first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Saxon Interests held 1,217 shares of Eli Lilly worth $1.46M as of Q2 2026.
  • Saxon Interests bought 334 Eli Lilly shares in Q2 2026, an estimated $341K.
  • Eli Lilly made up 0.4% of Saxon Interests's portfolio in Q2 2026, its #57 holding.
  • Saxon Interests first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Saxon Interests's 13F filing for Q2 2026, filed 12 Aug 2026.